M1413 Pos pdl1 bef initial ici treatment
M-Codes
Also known as: PD-L1 positive status, tumor PD-L1 expression, pos pdl1 bef init ici
Performance measure documenting positive Programmed Death-Ligand 1 (PD-L1) expression before initiation of immunotherapy in metastatic non-small cell lung cancer.
Clinical Context
Documents PD-L1 tumor expression status before immunotherapy initiation. Critical for first-line immunotherapy patient selection in NSCLC.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.